New Patients
Patient Portal
Referring Physicians
Forms Library
Sign Up to Win

Email Signup

Learn more

Enter your email address:

Hormone Therapy Risk - Benefit Ratio Favors Use in Newly Menopausal

An article published in the August, 2010 edition of Ob/Gyn News discuses the benefit/risk ratio of hormone therapy use in newly menopausal women.  In the article Dr. Richard Santen, professor of medicine at the University of Virginia, Charlottesville comments on the analysis and related statement written on behalf of the Endocrine Society.  The article also includes comments from Dr. Cynthia Stuenkel, president of the North American Menopause Society, clinical professor or medicine at the University of California, San Diego School of Medicine and an attending physician for the University's Endocrinology and Metabolism Service.  Click here for the full article. 

This is also listed in these categories...

Our unique blend of care gives you many options.  We invite you to explore our online menopause "suite" that addresses "all things menopause" including hormone and complementary therapies.  




If you are seeing this, you have attempted to link to the UpToDate widget but are experiencing a problem. Please visit UpToDate for more information.

© 2010 Baystate Ob/Gyn Group, Inc. • The entire content of this site (“Site”) including but not limited to text, graphics, images, links, documents, and other material ("Content") is for informational purposes only. The Content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Read entire disclaimer